chr17-73208408-C-G
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting
The NM_018714.3(COG1):c.2900C>G(p.Pro967Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000502 in 1,614,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_018714.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152234Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000490 AC: 123AN: 251270 AF XY: 0.000501 show subpopulations
GnomAD4 exome AF: 0.000521 AC: 761AN: 1461870Hom.: 0 Cov.: 32 AF XY: 0.000496 AC XY: 361AN XY: 727232 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000322 AC: 49AN: 152352Hom.: 0 Cov.: 33 AF XY: 0.000295 AC XY: 22AN XY: 74504 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
COG1 congenital disorder of glycosylation Uncertain:3
This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 967 of the COG1 protein (p.Pro967Arg). This variant is present in population databases (rs147588256, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with COG1-related conditions. ClinVar contains an entry for this variant (Variation ID: 324978). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
The COG1 c.2900C>G (p.Pro967Arg) variant, to our knowledge, has not been reported in the medical literature. The highest population minor allele frequency in the population database genome aggregation database (v.2.1.1) is 0.088% in the European non-Finnish population. Computational predictors suggest that the variant does not impact COG1 function. This variant has been reported in the ClinVar database as a germline variant of uncertain significance by three submitters. Due to limited information, and based on ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), the clinical significance of this variant is uncertain at this time. -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Inborn genetic diseases Uncertain:1
The c.2900C>G (p.P967R) alteration is located in exon 14 (coding exon 14) of the COG1 gene. This alteration results from a C to G substitution at nucleotide position 2900, causing the proline (P) at amino acid position 967 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at